MedTrace Logo

Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery

NCT02558218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-09-23

No results posted yet for this study

Summary

Primary objective of the study is the assessment of the patients' discomfort and ocular redness following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.

Conditions

  • Cataract

Interventions

DRUG

Systane Ultra

Further to standard medication (tobradex quid for 20 days), participants were administered Systane Ultra quid for 2 months

DRUG

tobradex quid (Standard)

Standard medication (tobradex quid for 20 days)

Sponsors & Collaborators

  • Democritus University of Thrace

    lead OTHER

Principal Investigators

  • Georgios Labiris, MD, PhD · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02558218 on ClinicalTrials.gov